Since CRP is part of the initial innate immune system response to inflammatory triggers, reduction in CRP levels could suggest a lower incidence of acute and initial-phase diabetes onset and attenuation of the perpetual inflammatory cycle. This evidence concerns the gene CRP and diabetes mellitus.